Skip to main content

The Age of Biosimilars In Oncology: How to Navigate Options for Your Practice and Patients

Stephanie Mayfield, PharmD
Director, Practice Consulting Cardinal Health, VitalSource (TM)
Matthew Moser, PharmD, CPh
Lead Clinical Pharmacy Specialist
Health First Cancer Institute
Sonia T. Oskouei
Cardinal Health

Live webinar occurred on February 9, 2021.

This preview is provided by Cardinal Health. Please use the link below to watch the full presentation.

View Full Webiniar

Note: By clicking the link above you will be leaving OPM's website

Biosimilars—a fast-growing class of therapeutic products that are highly similar to and have no clinically meaningful differences from existing FDA-approved branded biologics—are poised to bring significant cost savings opportunities in oncology, while maintaining high quality patient care. While some providers are actively using biosimilars in patient care, others feel challenged with navigating the economic, clinical and operational implications of adopting biosimilars. Join our webinar discussion to learn about the key challenges and real-life best practices for biosimilar adoption, including how tools, processes and expert support from VitalSource (TM) GPO help practices navigate the dynamic and rapidly evolving landscape.

Related Items